TITLE

Induced pluripotent stem cells: the new patient?

AUTHOR(S)
Bellin, Milena; Marchetto, Maria C.; Gage, Fred H.; Mummery, Christine L.
PUB. DATE
November 2012
SOURCE
Nature Reviews Molecular Cell Biology;Nov2012, Vol. 13 Issue 11, p713
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Worldwide increases in life expectancy have been paralleled by a greater prevalence of chronic and age-associated disorders, particularly of the cardiovascular, neural and metabolic systems. This has not been met by commensurate development of new drugs and therapies, which is in part owing to the difficulty in modelling human diseases in laboratory assays or experimental animals. Patient-specific induced pluripotent stem (iPS) cells are an emerging paradigm that may address this. Reprogrammed somatic cells from patients are already applied in disease modelling, drug testing and drug discovery, thus enabling researchers to undertake studies for treating diseases 'in a dish', which was previously inconceivable.
ACCESSION #
82671208

 

Related Articles

  • Health, innovation and iPS stem cells: Why co-operation matters. Shinya Yamanaka // OECD Observer;2014 OECD Yearbook, p82 

    The article focuses on stem cell technology known as iPS cells. It is noted that iPS cells have been developed as a world's first by the research group in 2006 and are produced by taking skin, blood or other somatic cells from humans or animals. It is mentioned that creation of cells that were...

  • Safety of induced stem cells gets a boost. Baker, Monya // Nature;1/10/2013, Vol. 493 Issue 7431, p145 

    The article focuses on a study conducted by researcher Masumi Abe and his team regarding induced pluripotent stem (iPS) cells derived from mice, which found that these cells perform worse than embryonic stem (ES) cells. Researcher Yang Xu claims that all concerns about the immune response...

  • Reprogramming of Adult Retinal Müller Glial Cells into Human-Induced Pluripotent Stem Cells as an Efficient Source of Retinal Cells. Slembrouck-Brec, Amélie; Rodrigues, Amélie; Rabesandratana, Oriane; Gagliardi, Giuliana; Nanteau, Céline; Fouquet, Stéphane; Thuret, Gilles; Reichman, Sacha; Orieux, Gael; Goureau, Olivier // Stem Cells International;7/15/2019, p1 

    The reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) has broad applications in regenerative medicine. The generation of self-organized retinal structures from these iPSCs offers the opportunity to study retinal development and model-specific retinal disease with...

  • Efficient Generation of iPS Cells from Skeletal Muscle Stem Cells. Kah Yong Tan; Eminli, Sarah; Hettmer, Simone; Hochedlinger, Konrad; Wagers, Amy J. // PLoS ONE;2011, Vol. 6 Issue 10, p1 

    Reprogramming of somatic cells into inducible pluripotent stem cells generally occurs at low efficiency, although what limits reprogramming of particular cell types is poorly understood. Recent data suggest that the differentiation status of the cell targeted for reprogramming may influence its...

  • Rationale and Methodology of Reprogramming for Generation of Induced Pluripotent Stem Cells and Induced Neural Progenitor Cells. Zuojun Tian; Fuzheng Guo; Biswas, Sangita; Wenbin Deng // International Journal of Molecular Sciences;2016, Vol. 17 Issue 4, p594 

    Great progress has been made regarding the capabilities to modify somatic cell fate ever since the technology for generation of induced pluripotent stem cells (iPSCs) was discovered in 2006. Later, induced neural progenitor cells (iNPCs) were generated from mouse and human cells, bypassing some...

  • CD166pos Subpopulation From Differentiated Human ES and iPS Cells Support Repair of Acute Lung Injury. Soh, Boon Seng; Zheng, Dahai; Li Yeo, Julie Su; Yang, Henry He; Ng, Shi Yan; Wong, Lan Hiong; Zhang, Wencai; Li, Pin; Nichane, Massimo; Asmat, Atasha; Wong, Poo Sing; Wong, Peng Cheang; Su, Lin Lin; Mantalaris, Sakis A; Lu, Jia; Xian, Wa; McKeon, Frank; Chen, Jianzhu; Lim, Elaine Hsuen; Lim, Bing // Molecular Therapy;Dec2012, Vol. 20 Issue 12, p2335 

    Previous efforts to derive lung progenitor cells from human embryonic stem (hES) cells using embryoid body formation or stromal feeder cocultures had been limited by low efficiencies. Here, we report a step-wise differentiation method to drive both hES and induced pluripotent stem (iPS) cells...

  • Mesodermal iPSC-derived progenitor cells functionally regenerate cardiac and skeletal muscle. Quattrocelli, Mattia; Swinnen, Melissa; Giacomazzi, Giorgia; Camps, Jordi; Barthélemy, Ines; Ceccarelli, Gabriele; Caluwé, Ellen; Grosemans, Hanne; Thorrez, Lieven; Pelizzo, Gloria; Muijtjens, Manja; Verfaillie, Catherine M.; Blot, Stephane; Janssens, Stefan; Sampaolesi, Maurilio // Journal of Clinical Investigation;12/1/2015, Vol. 125 Issue 12, p4463 

    Conditions such as muscular dystrophies (MDs) that affect both cardiac and skeletal muscles would benefit from therapeutic strategies that enable regeneration of both of these striated muscle types. Protocols have been developed to promote induced pluripotent stem cells (iPSCs) to differentiate...

  • Genetic correction of β-thalassemia patient-specific iPS cells and its use in improving hemoglobin production in irradiated SCID mice. Wang, Yixuan; Zheng, Chen-Guang; Jiang, Yonghua; Zhang, Jiqin; Chen, Jiayu; Yao, Chao; Zhao, Qingguo; Liu, Sheng; Chen, Ke; Du, Juan; Yang, Ze; Gao, Shaorong // Cell Research;Apr2012, Vol. 22 Issue 4, p637 

    The generation of induced pluripotent stem cells (iPSCs) from differentiated somatic cells by over-expression of several transcription factors has the potential to cure many genetic and degenerative diseases currently recalcitrant to traditional clinical approaches. One such genetic disease is...

  • Pluripotent State Induction in Mouse Embryonic Fibroblast Using mRNAs of Reprogramming Factors. El-Sayed, Ahmed Kamel; Zhentao Zhang; Lei Zhang; Zhiyong Liu; Abbott, Louise C.; Yani Zhang; Bichun Li // International Journal of Molecular Sciences;2014, Vol. 15 Issue 12, p21840 

    Reprogramming of somatic cells has great potential to provide therapeutic treatments for a number of diseases as well as provide insight into mechanisms underlying early embryonic development. Improvement of induced Pluripotent Stem Cells (iPSCs) generation through mRNA-based methods is...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics